invivodata Announces Drug Information Association (DIA) Annual Meeting Activities

New SitePRO Tablet and PRO Consulting Services to be Highlighted

PITTSBURGH — June 11, 2008 — invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, will demonstrate multiple product enhancements and new ePRO solutions at the Drug Information Association (DIA) Annual Meeting in Boston, June 22–26. Scientists from invivodata’s PRO Consulting® division will be featured speakers at this global industry event.

In Booth No. 600, invivodata representatives will showcase its second-generation, large-screen, site-based ePRO solution — the SitePRO^® Tablet. The SitePRO Tablet’s full-sized, 12-inch diagonal display screen allows for more accurate transition from paper to electronic assessments, in either landscape or portrait mode, and handles large scales without compromise. invivodata will also demonstrate enhancements to its field-based eDiary system, DiaryPRO^®.

Scientists from invivodata’s PRO Consulting division will be available in Booth No. 600 to answer trial sponsors’ questions about selecting PRO measures to assess treatment effect in support of regulatory submissions. As experts in the area of measuring signs and symptoms that are the basis of the primary endpoints, PRO Consulting scientists provide strategic services to help sponsors optimize PRO data collection in clinical trials and adhere to regulatory guidelines, including endpoint model development and ePRO instrument validation.

invivodata and PRO Consulting scientists will be featured presenters at the DIA Annual Meeting as follows:

Arthur Stone, Ph.D., will chair a panel on “Applying ePRO in Special Populations” (Tuesday, 8–9:30 a.m.)
Jean Paty, Ph.D., will present “The Role of eDiaries in Driving and Monitoring Patient Compliance to Clinical Trial Procedures” in the session “Enhancing Patient Compliance in Clinical Trials with e-Technology” (Tuesday, 10–11:30 a.m.)
Brian Tiplady, Ph.D., will present “Electronic Patient Diaries: Validation in an Unsupervised Setting” in the session “eSources: What Are They and How Do We Deal with Them?” (Wednesday, 10:30 a.m.–noon)
Jean Paty, Ph.D., will present “Psychometric Validation for Electronic Patient Reported Outcomes" in the session “Anatomy of ePRO Validation” (Wednesday, 8:30–10:00 a.m.)

About invivodata inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata’s electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata’s solutions include comprehensive trial-support services that facilitate the collection of ePRO data, and web-based access to study data operational reports that give researchers and sponsors visibility into study progress and improve trial efficiencies. invivodata’s solution has been used in more than 200 trials and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.

About PRO Consulting
PRO Consulting, a division of invivodata inc., provides consulting services to help clinical research teams effectively develop, execute and document patient reported outcome (PRO) strategies to support their clinical research objectives. The PRO Consulting team has more than 140 years of cumulative experience in psychometrics, PRO study design, migrating and validating electronic solutions to collect PRO data, and has extensive experience working with the FDA and other regulatory bodies.

RSS Feed